Type 1 diabetes
Amarna Therapeutics and NorthX Biologics collaborate to advance gene therapy for type 1 diabetes
July 10, 2025Mergers and Acquisitions, Research and Development Amarna Therapeutics, Diabetes, Immunology, NorthX Biologics, Type 1 diabetes, gene therapy, immune-mediated diseases
Amarna Therapeutics and NorthX Biologics have finalised an agreement to accelerate the development of Nimvec AM510, a gene therapy targeting …
First cellular therapy for patients with type 1 diabetes approved by FDA
June 29, 2023Medical Communications Diabetes, FDA, Lantidra, Type 1 diabetes, diabetes
The US Food and Drug Administration (FDA) has announced that it has approved Lantidra, the first allogeneic (donor) pancreatic islet …
ViaCyte and Gore collaborate on new diabetes treatments
March 3, 2021Research and Development Type 1 diabetes, diabetes, diabetes treatment, gore, viacyte
Clinical stage medicine company ViaCyte have extended their collaboration with materials science organisation Gore to develop new candidates for the …
Fast-acting mealtime insulin approved for children with diabetes in Canada
March 10, 2020Manufacturing and Production Type 1 diabetes, diabetes, insulin, insulin pump, type 2 diabetes
Health Canada has approved Novo Nordik’s Fiasp, a faster acting mealtime insulin, for children aged 2 and above with type …
Insulin pumps tied to over 2,000 injuries recalled
February 14, 2020Medical Communications Type 1 diabetes, diabetes, insulin, type 1, type 2, type 2 diabetes
Over 300,000 insulin pumps have been recalled by Medtronic after injuries and one death were reported due to devices malfunctioning. …
Type 2 diabetes cases up 40% in Scotland
February 11, 2020Manufacturing and Production Type 1 diabetes, diabetes, diabetes obesity, obesity, type 2 diabetes
According to a new study, Scotland’s cases of type 2 diabetes has increased by 40% over the last 10 years. …
Novo Nordisk to offer US patient’s in immediate need free insulin
January 3, 2020Medical Communications Novo, Novo Nordisk, Type 1 diabetes, diabetes, insulin, type 2 diabetes
Novo Nordisk said it would offer free, one-time supply of insulin to those in need, amidst rising insulin prices. Novo …
FDA approves artificial pancreas developed by the University of Virginia
January 2, 2020Business Services, Medical Communications FDA, Pancreas, Type 1 diabetes, diabetes, insulin, type 2 diabetes
The FDA has approved an artificial pancreas system based on technology from the University of Virginia’s Center for Diabetes Technology. …
Promising Phase 3 data for Sanofi’s Toujeo secures CHMP recommendation of label expansion in type 1 diabetes
November 4, 2019Research and Development, Sales and Marketing EU, Sanofi, Type 1 diabetes, diabetes, pharma, toujeo
Sanofi took the opportunity at the International Society for Pediatric and Adolescent Diabetes 45th Annual Conference in Boston, Massachusetts to …
Sanofi and Lexicon’s Zynquista scores EU approval for type 1 diabetes patients
April 29, 2019Sales and Marketing Lexicon, Sanofi, Type 1 diabetes, Zynquista, diabetes, pharma
The European Commission has authorised the use of Sanofi and Lexicon’s Zynquista (sotagliflozin) in Europe in the treatment of specific …
Insider Interview: The diabetes/mental health connection
December 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Type 1 diabetes, World Diabetes Day, diabetes, feature, mental health, pharma
Michael Connellan, Head of External Affairs at the type 1 diabetes charity JDRF, discusses the results of a recent survey …
Novo Nordisk’s Fiasp shows strong blood sugar control in under-18 type 1 diabetes patients
October 12, 2018Medical Communications, Research and Development Fiasp, Novo Nordisk, Type 1 diabetes, diabetes, pharma
New data unveiled by Novo Nordisk has shown that its insulin injection Fiasp (fast-acting insulin aspart) could provide a better …
Pioneering immunotherapy halts progression of type 1 diabetes
August 10, 2017Research and Development Type 1 diabetes, diabetes, drugs, insulin, life sciences, medicines, pharma, pharmaceutical
In a first for the disease area, an immunotherapy treatment for diabetes, developed by researchers at King’s College London and …
Reversal of type 1 diabetes possible through century-old vaccine
June 14, 2017Research and Development BCG, Type 1 diabetes, Vaccine, diabetes
The American Diabetes Association 77th Scientific Sessions closed yesterday and one of the most interesting pieces of research to emerge …
Sanofi joins Google in diabetes tech push
September 1, 2015Medical Communications Andy Conrad, Google life sciences, Sanofi, Type 1 diabetes, diabetes, google, type 2 diabetes
Google is continuing its work in diabetes, by teaming up with pharma giants Sanofi to create new digital technologies and …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
